Francesca Urbano

Catania, 95131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Increased Platelet Reactivity and Proinflammatory Profile Are Associated with Intima-Media Thickness and Arterial Stiffness in Prediabetes.

Increased Platelet Reactivity and Proinflammatory Profile Are Associated with Intima-Media Thickness and Arterial Stiffness in Prediabetes.

Journal: Journal of clinical medicine

Published: April 14, 2022

High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects.

High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: March 17, 2021

Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress.

Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress.

Journal: Scientific reports

Published: December 11, 2020

Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: A single lipid center real-world experience.

Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: A single lipid center real-world experience.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: October 12, 2020

1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease.

1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease.

Journal: Cells

Published: July 29, 2019

Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation.

Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation.

Journal: Scientific reports

Published: July 29, 2019

Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview.

Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview.

Journal: International journal of molecular sciences

Published: March 22, 2019

Impaired glucagon suppression and reduced insulin sensitivity in subjects with prediabetes undergoing atorvastatin therapy.

Impaired glucagon suppression and reduced insulin sensitivity in subjects with prediabetes undergoing atorvastatin therapy.

Journal: European journal of endocrinology

Published: March 18, 2019

Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity.

Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: December 20, 2018

Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia.

Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia.

Journal: Acta diabetologica

Published: November 02, 2018

Chronic Exposure to Palmitate Impairs Insulin Signaling in an Intestinal L-cell Line: A Possible Shift from GLP-1 to Glucagon Production.

Chronic Exposure to Palmitate Impairs Insulin Signaling in an Intestinal L-cell Line: A Possible Shift from GLP-1 to Glucagon Production.

Journal: International journal of molecular sciences

Published: October 08, 2018

New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.

New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.

Journal: Acta diabetologica

Published: October 20, 2017

Showing 1-12 of 27

Last Updated: 09/26/2026